AdiaVita stem cell IV trial charges patients $5,000 for back pain
New 100-patient trial will test AdiaVita IV for lower back pain at $5,000 per person, a less invasive option that builds on Adia’s 24‑month autism study.
With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Brain
TUESDAY, May 5, 2026 U.S. Supreme Court Justice Samuel Alito Jr. issued an order Monday that allows patients to continue accessing abortion pill, mifepristone, Post Views: 0